Baring India backs drug developer

The Delhi-based private equity firm will invest up to $15m in Sphaera Pharma. It is the first deal for its $550m Fund III closed earlier this year.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this